Previous 10 | Next 10 |
Insys Therapeutics (NASDAQ:INSY) is back in the news this week, after agreeing last Friday to pay a $225 million settlement to resolve criminal investigations regarding its role in marketing opioids, an addictive painkiller. This week, we’ve seen INSY close at a record low after th...
PHOENIX, June 12, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY) (“INSYS” or the “Company”), a specialty pharmaceutical development and distribution company, announced that on June 11, 2019 INSYS received interim approvals from the U.S. Bankrupt...
Quick Take Stoke Therapeutics ( STOK ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing therapeutics for severe genetic diseases with a focus on dominant loss-of-function [haploinsufficient] diseases of ...
INSYS Therapeutics (NASDAQ: INSY ) -63% on filing Chapter 11 for bankruptcy. More news on: INSYS Therapeutics, Inc., Spark Therapeutics, Inc., Genocea Biosciences, Inc., Stocks on the move, Read more ...
Buckling under the weight of opioid lawsuits, INSYS Therapeutics (NASDAQ: INSY ) has filed for Chapter 11 bankruptcy and will sell substantially all of its assets. More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Company to Facilitate Transaction Process and Sale of Substantially All Assets Through Chapter 11 of the U.S. Bankruptcy Code Operations to Continue as Normal Including Payment of Employee Wages and Benefits and Continuing Programs for Customers; Vendors and Suppliers to Receive Full ...
Trying times for Insys Therapeutics (NASDAQ:INSY) have finally come to an end—but at a price. On Friday, the opioid manufacturer said it has agreed to pay a whopping $225 million to settle criminal investigations. And yet, the market doesn’t seem to mind: INSY stock is up mo...
Charles & Colvard (NASDAQ: CTHR ) -19% on Q4 and FY guidance and equity offering . More news on: Charles & Colvard, Ltd., Motif Bio plc, Domo, Inc., Stocks on the move, Read more ...
Insys Therapeutics (NASDAQ: INSY ) has been halted for volatility after an 81% jump . More news on: INSYS Therapeutics, Inc., Healthcare stocks news, Stocks on the move Read more ...
Today's Top Stories: ECB eyed amid central bank shift; more gains; and tech cold war. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher SoundCloud ...
News, Short Squeeze, Breakout and More Instantly...
Insys Therapeutics Inc. Company Name:
INSY Stock Symbol:
NASDAQ Market:
Insys Therapeutics Inc. Website:
GD Entertainment and Technology’s (OTC: GDET ) Anil Idnani, CEO, will discuss the company’s 2020 outlook when he is interviewed by Stock Market Podcast. He will focus on GDET’s new customizable, prepaid ‘Dream Card’ and also the marketing of its CBD produc...
GD Entertainment and Technology (OTC: GDET ) announces today (June 15, 2020) that Anil Idnani, CEO,will be interviewed by Stock Market Podcast and offer a review of the company’s marketing growth and 2020 outlook. The company is focusing on both its re-introduced customizable, ...
Reinforcing the strength of CBD sales, website 420 Intel reported that sales of CBD hit $103 million for the month of May — the state’s first $100 million-plus month — representing a 15% jump over April and a 60% YOY spike from May last year. It was the third straight mo...